Standard Biotools (LAB) Capital Expenditures (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104.57% |
| Dec 31, 2025 | -887.36% |
| Sep 30, 2025 | -53.05% |
| Jun 30, 2025 | -62.66% |
| Mar 31, 2025 | 474.97% |
| Dec 31, 2024 | 149.30% |
| Sep 30, 2024 | -192.05% |
| Jun 30, 2024 | 148.02% |
| Mar 31, 2024 | 128.37% |
| Dec 31, 2023 | -404.20% |
| Sep 30, 2023 | 8.00% |
| Jun 30, 2023 | -17.03% |
| Mar 31, 2023 | 33.77% |
| Dec 31, 2022 | -40.27% |
| Sep 30, 2022 | 34.75% |
| Jun 30, 2022 | 8.06% |
| Mar 31, 2022 | 73.60% |
| Dec 31, 2021 | -96.09% |
| Sep 30, 2021 | 15.38% |
| Jun 30, 2021 | 60.26% |
| Mar 31, 2021 | -35.34% |
| Dec 31, 2020 | 3,058.41% |
| Sep 30, 2020 | -47.11% |
| Jun 30, 2020 | -37.77% |
| Mar 31, 2020 | 106.00% |
| Dec 31, 2019 | -62.85% |
| Sep 30, 2019 | 221.24% |
| Jun 30, 2019 | 57.52% |
| Mar 31, 2019 | 1,230.00% |
| Dec 31, 2018 | -89.90% |
| Sep 30, 2018 | 157.14% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | -56.74% |
| Dec 31, 2017 | -67.87% |
| Sep 30, 2017 | 290.14% |
| Jun 30, 2017 | -79.48% |
| Mar 31, 2017 | -0.29% |
| Dec 31, 2016 | -59.39% |
| Sep 30, 2016 | 12.58% |
| Jun 30, 2016 | 32.69% |
| Mar 31, 2016 | -20.39% |
| Dec 31, 2015 | 511.49% |
| Sep 30, 2015 | -83.23% |
| Jun 30, 2015 | 54.13% |
| Mar 31, 2015 | -38.75% |
| Dec 31, 2014 | 9.44% |
| Sep 30, 2014 | -50.69% |
| Jun 30, 2014 | 51.68% |
| Mar 31, 2014 | -3.62% |
| Dec 31, 2013 | 188.06% |
| Sep 30, 2013 | 205.14% |
| Jun 30, 2013 | -69.34% |
| Mar 31, 2013 | -8.52% |
| Dec 31, 2012 | 99.74% |
| Sep 30, 2012 | -54.63% |
| Jun 30, 2012 | 112.09% |
| Mar 31, 2012 | -41.53% |
| Dec 31, 2011 | 139.93% |
| Sep 30, 2011 | -42.71% |
| Jun 30, 2011 | 124.55% |
| Mar 31, 2011 | -46.21% |
| Dec 31, 2010 | -13.35% |